Product Information

QUETIAPINE FUMARATE 300 MG TAB is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1352 per EA under NDC 00093816401. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Mar 27, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

QUETIAPINE FUMARATE 300 MG TAB

Quetiapine
$0.1352per EA

Strength

300 mg/1

NDC

00093816401

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

QUETIAPINE FUMARATE

Approval Type

Generic (ANDA)

FDA Application

ANDA077745

FDA Approved

3/27/2012

TE Code

AB

On Market Since

3/27/2012

Pharmacological Classes

Price Statistics

The NADAC for QUETIAPINE FUMARATE 300 MG TAB has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 70.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1352 per EA
All-time high$0.4855 (Feb 12, 2014)
All-time low$0.1136 (Nov 20, 2024)
52-week high$0.1465
52-week low$0.1265
Median price$0.1760
Average price$0.2231
Largest weekly change-26.7% (Nov 20, 2024)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

+5.8%

1M

+6.1%

3M

+5.2%

6M

-7.7%

1Y

+2.9%

3Y

-8.4%

5Y

-5.1%

All

-70.3%

Generic Alternatives

The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of QUETIAPINE FUMARATE 300 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE FUMARATE 300 MG TAB, manufactured by Teva Pharmaceuticals USA Inc., is $0.1352 per EA (NDC 00093816401), effective Nov 18, 2026.

How has the price of QUETIAPINE FUMARATE 300 MG TAB changed over time?

Over the history we have for it, the NADAC for QUETIAPINE FUMARATE 300 MG TAB has declined 70.3%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for QUETIAPINE FUMARATE 300 MG TAB?

Since Nov 28, 2013, the NADAC for QUETIAPINE FUMARATE 300 MG TAB has ranged from a low of $0.1136 (Nov 20, 2024) to a high of $0.4855 (Feb 12, 2014), with a median of $0.1760 per EA.

Are there cheaper alternatives to QUETIAPINE FUMARATE 300 MG TAB?

Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QUETIAPINE FUMARATE 300 MG TAB, is $0.1330 per EA — about 2% below QUETIAPINE FUMARATE 300 MG TAB.

Who manufactures QUETIAPINE FUMARATE 300 MG TAB?

QUETIAPINE FUMARATE 300 MG TAB (NDC 00093816401) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.